RITALIN LA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ritalin La, and what generic alternatives are available?
Ritalin La is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in RITALIN LA is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ritalin La
A generic version of RITALIN LA was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
Summary for RITALIN LA


See drug prices for RITALIN LA

Recent Clinical Trials for RITALIN LA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kuwait University | Early Phase 1 |
University of Haifa | Phase 2 |
Maccabi Healthcare Services, Israel | Phase 2/Phase 3 |
Pharmacology for RITALIN LA
Drug Class | Central Nervous System Stimulant |
Physiological Effect | Central Nervous System Stimulation |
Anatomical Therapeutic Chemical (ATC) Classes for RITALIN LA
Paragraph IV (Patent) Challenges for RITALIN LA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
RITALIN LA | Extended-release Capsules | methylphenidate hydrochloride | 10 mg | 021284 | 1 | 2007-05-21 |
RITALIN LA | Extended-release Capsules | methylphenidate hydrochloride | 20 mg, 30 mg and 40 mg | 021284 | 2006-08-21 |
US Patents and Regulatory Information for RITALIN LA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-004 | Apr 10, 2004 | AB1 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-003 | Jun 5, 2002 | AB1 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-001 | Jun 5, 2002 | AB1 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-002 | Jun 5, 2002 | AB1 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-005 | Oct 27, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RITALIN LA
International Patents for RITALIN LA
See the table below for patents covering RITALIN LA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2010265299 | IMPROVED DELIVERY OF MULTIPLE DOSES OF MEDICATION | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 9903471 | ⤷ Try a Trial | |
Australia | 770645 | ⤷ Try a Trial | |
European Patent Office | 2032137 | ⤷ Try a Trial | |
Israel | 196065 | ⤷ Try a Trial | |
South Korea | 20080024206 | ⤷ Try a Trial | |
New Zealand | 511442 | Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |